Eledon Pharmaceuticals
ELDN
ELDN
31 hedge funds and large institutions have $15.9M invested in Eledon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
31
Holding in Top 10
–
Calls
$57K
Puts
–
Top Buyers
| 1 | +$33.6K | |
| 2 | +$11K | |
| 3 | +$5.06K | |
| 4 |
Morgan Stanley
New York
|
+$684 |
Top Sellers
| 1 | -$382K | |
| 2 | -$311K | |
| 3 | -$134K | |
| 4 |
V
Veritable
Wilmington,
Delaware
|
-$130K |
| 5 |
Two Sigma Advisers
New York
|
-$95.4K |